ltra-hypofractionated Breast Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast Cancer

Not Applicable

Recruiting

• Conditions: Breast Cancer

• Registration Number: JPRN-UMIN000047080
• Lead Sponsor: Kobe City Medical Center General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-03-07
• Last Update Posted: 17 October 2023
• Study Completion: 2029-03-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 98

Inclusion Criteria

Not provided

Exclusion Criteria

1.Prior malignancies; except another malignancy and disease-free for > 5 years, or completely resected or successfully treated in situ carcinoma. 2.Infection with systemic therapy indicated 3.Body temperature of 38 or more degrees Celsius 4.Women during pregnancy, possible pregnancy or breast-feeding 5.Psychosis 6.Uncontrollable diabetes mellitus or administration of insulin 7.Interstitial pneumonia, pulmonary fibrosis, or severe emphysema. 8.Systemic steroids medication. 9.Immunosuppressant for active collagen disease. 10.History of severe heart disease, heart failure, myocardial infarction within 6 months or attack of angina pectoris within 6 months. 11.The patient inappropriate for entry into this study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence rate of late adverse events within 3 years

Secondary Outcome Measures

Name	Time	Method
Overall survival, Progression-free survival, Ipsilateral breast tumour recurrence free survival, Ipsilateral breast tumour recurrence free rates, Incidence rate of acute adverse events within 3 months, Incidence rate of late adverse events within 5 years.